Clinical Trial Update: Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update investigates feed-back suppression of meal-induced GLP-1 secretion in people with Type 2 diabetes. The study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Michael A. Nauck | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED